Oestrogen ring showed no clear difference in adverse events (total adverse events) (oestrogen ring vs placebo) compared with other regimens (moderate certainty).
Oestrogen tablets showed no clear difference in adverse events (total adverse events) (oestrogen tablets vs placebo) compared with other regimens (moderate certainty).
D‐cycloserine showed no clear difference in total adverse events compared with placebo (low certainty).
The review found no eligible studies for this question.
Tacrolimus showed no clear difference in total adverse events compared with placebo (low certainty).
It is very uncertain whether summary of findings table ‐ Stem Cell changes total Adverse Events compared with placebo or Control (very low certainty).
High‐dose colchicine may leads to higher total adverse events compared with placebo (low certainty).
Low‐dose colchicine showed no clear difference in total adverse events compared with placebo (low certainty).
Monthly pegloticase showed no clear difference in total adverse events compared with placebo (moderate certainty).
Pegloticase every two weeks (biweekly) showed no clear difference in total adverse events compared with placebo (moderate certainty).
NSAIDs showed no clear difference in total adverse events compared with placebo (low certainty).
Summary of Findings Table ‐ IncobotulinumtoxinA 20U showed no clear difference in total adverse events compared with placebo (low certainty).
Summary of Findings Table ‐ DaxibotulinumtoxinA 40U probably leads to higher total adverse events compared with placebo (moderate certainty).
Summary of Findings Table ‐ OnabotulinumtoxinA 20U showed no clear difference in total adverse events compared with placebo (low certainty).
Summary of Findings Table ‐ AbobotulinumtoxinA 50U may leads to higher total adverse events compared with placebo (low certainty).
Nefopam 60 mg tds may leads to higher total adverse events compared with placebo (low certainty).
Oromucosal cannabis (Sativex) may leads to higher total adverse events compared with placebo (low certainty).
Paracetamol showed no clear difference in total adverse events: number experiencing 24 weeks compared with placebo (high certainty).
It is very uncertain whether antihypertensive therapy changes total serious adverse events compared with placebo or no treatment (very low certainty).
Abatacept (2 and 10mg/kg) + DMARDs/biologic showed no clear difference in total serious adverse events compared with placebo + DMARDs/biologic (moderate certainty).